Investigator Initiated Multi-Site Clinical Trials (R01)

The summary for the Investigator Initiated Multi-Site Clinical Trials (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Investigator Initiated Multi-Site Clinical Trials (R01): -Purpose. The purpose of this Funding Opportunity Announcement is to provide a vehicle for submitting grant applications for investigator-initiated multi-site Phase II or Phase III randomized, controlled clinical trials. The trials may address any research question related to the mission and goals of NHLBI and may test clinical or behavioral interventions. Investigators should consult the NHLBI s Guidelines for Investigator Initiated Clinical Trials (http://www.nhlbi.nih.gov/funding/policies/clinical.htm) for more detailed instructions and information about multi-site clinical trial grant applications. Additional information about the mission, strategic plan and research interests of the NHLBI can be found at NHLBI s website (http://www.nhlbi.nih.gov/index.htm). -This Funding Opportunity Announcement is not intended for support of single-center studies or multi-center observational studies that are not testing an intervention. -Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism. Awards may be converted by NHLBI to cooperative agreements (U01).

Federal Grant Title:	Investigator Initiated Multi-Site Clinical Trials (R01)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAR-07-373
Type of Funding:	Grant
CFDA Numbers:	93.233
CFDA Descriptions:	National Center on Sleep Disorders Research
Current Application Deadline:	Multiple Receipt Dates - See Link to Full Announce
Original Application Deadline:	Multiple Receipt Dates - See Link to Full Announce
Posted Date:	May 14, 2007
Creation Date:	Dec 05, 2008
Archive Date:	Jun 07, 2010
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants: • Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborat...; • Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required); • Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collab...; • NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial N...; • Limited Competition: Regenerative Medicine Innovation Project (RMIP) Investigator-Initiate...; • Ancillary Studies in Clinical Trials (R01); • Opportunity PA-08-021; • Research Demonstration and Dissemination Grants (R18)
More Grants from the National Institutes of Health: • NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed); • Tuberculosis Research Advancement Centers (TRACs) (P30 Clinical Trial Not Allowed); • Coccidioidomycosis Collaborative Research Centers (P01 Clinical Trial Not Allowed); • Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowe...; • Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)